Donor cell reaction to OKT3 as predictor of chronic graft-vs-host disease in hematopoietic stem cell recipients

Experimental Hematology

Volumn 34, Issue 12, 2006, Pages 1753-1758

  Lindemann, Monika ^a   Ottinger, Hellmut D ^a   Elmaagacli, Ahmet H ^a   Trenschel, Rudolf ^a   Rebmann, Vera ^a   Beelen, Dietrich W ^a   Grosse Wilde, Hans ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; GRANULOCYTE COLONY STIMULATING FACTOR; HLA ANTIGEN; METHOTREXATE; MITOGENIC AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; CELLULAR IMMUNITY; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG MEGADOSE; DRUG RESPONSE; FEMALE; GRAFT RECIPIENT; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; LYMPHOCYTE; LYMPHOCYTE TRANSFORMATION TEST; MALE; MULTIVARIATE ANALYSIS; MYELODYSPLASTIC SYNDROME; PERIPHERAL BLOOD MONONUCLEAR CELL; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; STEM CELL; T LYMPHOCYTE; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; AGED; CELL PROLIFERATION; CHRONIC DISEASE; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MUROMONAB-CD3; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 33751550659     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2006.08.003     Document Type: Article

References (26)

1. Stem Cell Trialists' Collaborative Group. Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials. J Clin Oncol 23 (2005) 5074-5087
2. Schmitz N., Dreger P., Suttorp M., et al. Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor). Blood 85 (1995) 1666-1672
3. Levine J.E., Wiley J., Kletzel M., et al. Cytokine-mobilized allogeneic peripheral blood stem cell transplants in children result in rapid engraftment and a high incidence of chronic GVHD. Bone Marrow Transplant 25 (2000) 13-18
4. Storek J., Gooley T., Siadak M., et al. Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease. Blood 90 (1997) 4705-4709
5. Lindemann M., Rebmann V., Ottinger H.D., Schmolke K., and Kreuzfelder E. Grosse-Wilde H. rhG-CSF effect on mixed lymphocyte cultures and circulating soluble HLA antigen levels in volunteer stem cell donors. Exp Hematol 32 (2004) 1103-1109
6. Lindemann M., Ottinger H.D., Peceny R., Beelen D.W., and Grosse-Wilde H. G-CSF-induced alteration of in-vitro alloreactivity in stem cell donors is predictive for the occurrence of acute GvHD in recipients. Transplantation 79 (2005) 377-378
7. Ottinger H.D., Müller C.R., Goldmann S.F., et al. German consensus on immunogenetic donor search for transplantation of allogeneic bone marrow and peripheral blood stem cells. Bone Marrow Transplant 20 (1997) 101-105
8. Elmaagacli A.H., Basoglu S., Peceny R., et al. Improved disease-free-survival after transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical unrelated donors in patients with first chronic phase chronic myeloid leukemia. Blood 99 (2002) 1130-1135
9. Shulman H., Sullivan K., Weiden P., et al. Chronic graft-versus-host syndrome in man: a clinicopathological study of 20 long-term Seattle patients. Am J Med 69 (1980) 204-217
10. Lindemann M., Witzke O., Winterhagen T., et al. T-cell function after interleukin-2 therapy in HIV-infected patients is correlated with serum cortisol concentrations. AIDS 18 (2004) 2001-2007
11. Lindemann M., Böhmer J., Zabel M., and Grosse-Wilde H. ELISpot: a new tool for the detection of nickel sensitization. Clin Exp Allergy 33 (2003) 992-998
12. Ottinger H.D., Beelen D.W., Scheulen B., Schaefer U.W., and Grosse-Wilde H. Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow. Blood 88 (1996) 2775-2779
13. Metz C.E. Basic principles of ROC analysis. Semin Nucl Med 8 (1978) 283-298
14. Horwitz M.E., and Sullivan K.M. Chronic graft-versus-host disease. Blood Rev. 20 (2006) 15-27
15. Van Wauwe J.P., De Mey J.R., and Goossens J.G. OKT3: a monoclonal anti-human T lymphocyte antibody with potent mitogenic properties. J Immunol 124 (1980) 2708-2713
16. Arpinati M., Green C.L., Heimfeld S., Heuser J.E., and Anasetti C. Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells. Blood 95 (2000) 2484-2490
17. Dolezalova L., Vrana M., Dobrovolna M., et al. Cytotoxic T lymphocyte precursor frequency analysis in the selection of HLA matched unrelated donors for hematopoietic stem cell transplantation: the correlation of CTLp frequency with HLA class I genotyping and aGVHD development. Neoplasma 49 (2002) 26-32
18. Hromadnikova I., Sedlacek P., Stary J., et al. [A method for modeling skin explants-an in vitro predictive test for graft-vs-host disease in allogenic hematopoietic cell transplantation]. Cas Lek Cesk 140 (2001) 73-78 [Czech]
19. Carlens S., Ringden O., Remberger M., et al. Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis. Bone Marrow Transplant 22 (1998) 755-761
20. Cavet J., Middleton P.G., Segall M., Noreen H., Davies S.M., and Dickinson A.M. Recipient tumor necrosis factor-α and interleukin-10 gene polymorphisms associate with early mortality and acute graft-versus-host disease severity in HLA-matched sibling bone marrow transplants. Blood 94 (1999) 3941-3946
21. Cavet J., Dickinson A.M., Norden J., Taylor P.R., Jackson G.H., and Middleton P.G. Interferon-gamma and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation. Blood 98 (2001) 1594-1600
22. Holler E., Roncarolo M.G., Hintermeier-Knabe R., et al. Prognostic significance of increased IL-10 production in patients prior to allogeneic bone marrow transplantation. Bone Marrow Transplant 25 (2000) 237-241
23. Banning U., Lange T., Krahl R., et al. Prognostic value of T-1 cell numbers prior to allogeneic stem cell transplantation in patients with severe graft-versus-host disease. Bone Marrow Transplant 35 (2005) 691-697
24. Hazenberg M.D., Otto S.A., de Pauw E.S., et al. T-cell receptor excision circle and T-cell dynamics after allogeneic stem cell transplantation are related to clinical events. Blood 99 (2002) 3449-3453
25. Poulin J.F., Sylvestre M., Champagne P., et al. Evidence for adequate thymic function but impaired naive T-cell survival following allogeneic hematopoietic stem cell transplantation in the absence of chronic graft-versus-host disease. Blood 102 (2003) 4600-4607
26. Clave E., Rocha V., Talvensaari K., et al. Prognostic value of pretransplantation host thymic function in HLA-identical sibling hematopoietic stem cell transplantation. Blood 105 (2005) 2608-2613